TNFSF10 and cancer: Given that DR5 is a receptor for TRAIL, we speculated that B-Raf inhibition in Ras-mutant cancer cells will sensitize them to TRAIL-induced apoptosis due to a MEK/ERK-dependent increase in DR5 expression.